Workflow
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?
HologicHologic(US:HOLX) ZACKS·2025-07-10 13:26

Key Takeaways MyoSure and Fluent have powered HOLX's Surgical growth at a 7.6% CAGR over the last decade. HOLX sees solid uptake for Fluent Pro and growing demand abroad, boosting Surgical momentum. Acquisitions like Acessa and Gynesonics enhance HOLX's fibroid treatment and global market reach.The growing prevalence of gynecological diseases and increasing government investments to improve women’s health are fueling the demand for gynecology surgical instruments. According to Zion Market Research, the ma ...